Mark L Bernstein Selected Research

Mark L Bernstein Research Topics

Disease

16	Neoplasms (Cancer) 01/2019 - 02/2003
6	Osteosarcoma (Osteogenic Sarcoma) 01/2019 - 03/2005
5	Ewing Sarcoma (Sarcoma, Ewing) 03/2013 - 01/2006
4	Leukemia 10/2013 - 03/2002
3	Neuroblastoma 06/2010 - 04/2006
3	Leukemia L1210 02/2009 - 03/2005
2	Left Ventricular Dysfunction 01/2019 - 01/2016
2	Cardiotoxicity 01/2019 - 01/2016
2	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 10/2013 - 03/2002
2	Hypocalcemia 10/2007 - 02/2003
1	Sarcoma (Soft Tissue Sarcoma) 01/2019
1	Heart Failure 01/2019
1	Necrosis 01/2016
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 07/2011
1	Carcinogenesis 11/2008
1	Synovial Sarcoma (Synovioma) 02/2008
1	Body Weight (Weight, Body) 10/2007
1	Hypotension (Low Blood Pressure) 10/2007
1	Hypersensitivity (Allergy) 10/2007
1	Thrombosis (Thrombus) 10/2007
1	Anemia 10/2007
1	Catheter-Related Infections 10/2007
1	Primitive Neuroectodermal Tumors (PNET) 01/2006
1	Pancreatitis 09/2005
1	Hyperparathyroidism 09/2005
1	Disease Progression 09/2005
1	Medulloblastoma 05/2004
1	Brain Neoplasms (Brain Tumor) 05/2004
1	Ependymoma 05/2004
1	Infratentorial Neoplasms (Posterior Fossa Tumors) 05/2004
1	Metabolic Bone Diseases (Osteopenia) 05/2004
1	Neutropenia 07/2003
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 03/2002
1	Renal Insufficiency (Renal Failure) 03/2002

Drug/Important Bio-Agent (IBA)

4	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2019 - 03/2005
4	Methotrexate (Mexate)FDA LinkGeneric 01/2016 - 03/2002
4	Cisplatin (Platino)FDA LinkGeneric 01/2016 - 02/2003
3	Ifosfamide FDA LinkGeneric 01/2016 - 03/2005
3	Decitabine FDA Link 11/2008 - 03/2005
3	Antineoplastic Agents (Antineoplastics)IBA 11/2008 - 03/2005
2	Dexrazoxane (Zinecard)FDA LinkGeneric 01/2019 - 01/2016
2	AnthracyclinesIBA 01/2019 - 01/2016
2	Imatinib Mesylate (Gleevec)FDA Link 07/2011 - 02/2008
2	pyrimidin-2-one beta-ribofuranosideIBA 02/2009 - 03/2005
2	Irinotecan (Camptosar)FDA LinkGeneric 11/2008 - 02/2003
2	Topotecan (Hycamtin)FDA LinkGeneric 01/2006 - 03/2002
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2019
1	pro-brain natriuretic peptide (1-76)IBA 01/2019
1	microbial alkaline proteinase inhibitor (MAPI)IBA 01/2016
1	Etoposide (VP 16)FDA LinkGeneric 01/2016
1	Histones (Histone)IBA 11/2008
1	ChromatinIBA 11/2008
1	Cadherins (E-Cadherin)IBA 11/2008
1	entinostat (MS 275)IBA 11/2008
1	Histone Deacetylase InhibitorsIBA 11/2008
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 02/2008
1	Hemoglobins (Hemoglobin)IBA 10/2007
1	ParaffinIBA 05/2007
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 05/2007
1	Monoclonal AntibodiesIBA 05/2007
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2006
1	Calcitonin (Calcitonin, Eel)FDA LinkGeneric 09/2005
1	ErbB Receptors (EGF Receptor)IBA 09/2005
1	Interferon-alpha (Interferon Alfa)IBA 09/2005
1	Tyrosine Kinase InhibitorsIBA 09/2005
1	Gefitinib (Iressa)FDA Link 09/2005
1	Liposomes (Liposome)IBA 03/2005
1	Paclitaxel (Taxol)FDA LinkGeneric 07/2003
1	Amifostine (Ethyol)FDA LinkGeneric 02/2003
1	9 alpha,11 alpha,15 alpha- trihydroxy- 16- phenoxy- 17,18,19,20- tetranorprosta- 4,5,13- trienoic acid (TPT)IBA 03/2002
1	Mercaptopurine (6 Mercaptopurine)FDA LinkGeneric 03/2002

Therapy/Procedure

11	Therapeutics 01/2016 - 03/2002
8	Drug Therapy (Chemotherapy) 01/2016 - 03/2002
1	Induction Chemotherapy 01/2016
1	Complementary Therapies (Alternative Medicine) 10/2013
1	Intravenous Infusions 11/2008
1	Catheters 10/2007
1	Critical Care (Surgical Intensive Care) 10/2007
1	Blood Component Removal (Apheresis) 10/2007
1	Craniospinal Irradiation 05/2004